RECURRENT NON SMALL CELL LUNG CANCER
Clinical trials for RECURRENT NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for RECURRENT NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink lung tumors better than current standard
Disease control OngoingThis study tests whether adding a new immunotherapy drug (relatlimab) to the usual nivolumab-plus-chemotherapy treatment can shrink tumors more effectively in people with advanced or recurrent non-small cell lung cancer. About 468 participants will receive either the three-drug c…
Matched conditions: RECURRENT NON SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 17, 2026 09:18 UTC
-
Precision radiation boost shows promise for tough lung cancers
Disease control OngoingThis study tested a new way of giving radiation therapy (called image-guided hypofractionated radiotherapy with a stereotactic boost) along with standard chemotherapy for people with stage II-III non-small cell lung cancer that cannot be removed by surgery. The goal was to find t…
Matched conditions: RECURRENT NON SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC